You've been strangely silent on J.P's departure. Are you having misgivings about IDIX's ability to compete in the HCV arena? Why do you explain J.P.'s rather sudden departure?
Was J.P. the "brains" of the outfit or are other science types more responsible for the drug development pipeline?